UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Reading Time: < 1 minute

Oct 21 (Reuters) – The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday.

Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.


Once you're here...